Skip to main content
. 2022 Oct 17;63(2 Suppl 3):E174–E188. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2759

Tab. V.

Effect of phosphatidylserine on neurological conditions.

Neurological conditions Subjects Nutrients Findings References
Alzheimer’s disease Aged patients with AD and dementia Soy lecithin-derived phosphatidylserine plus phosphatidic acid Improved cognition, mood, and memory [58]
Attention deficit hyperactivity disorder (ADHD) Children with ADHD Phosphatidylserine Improved short-term auditory memory and ADHD symptoms [59]
Premenstrual syndrome (PMS) 40 women age 18-45 years diagnosed with PMS 400 mg PS + 400 mg PA per day or a matching placebo Significant reduction in PMS symptoms [60]
Cognitive impairment Elderly persons with impaired memory 100 mg/day phosphatidylserine enriched with docosahexaenoic acid (PS-DHA) May improve or maintain cognitive status [61]
Cognitive function improvement Elderly persons with impaired memory without dementia Phosphatidylserine enriched with docosahexaenoic acid (PS-DHA) May improve cognitive performance [62]
Acute cognitive effects Healthy young volunteers Ginkgo biloba extract with soy-derived PS Significantly improved memory task speed and improved secondary memory [63]
Cognition and cortical activity after mental stress Healthy subjects doing cognitive tasks under induced stress in a test–re-test design Phosphatidylserine supplementation Continued supplementation significantly was connected with a more relaxed state compared to the controls [64]
Age-related cognitive function 130 elderly persons with cognitive impairment PS derived from soybean 300 mg/day Safely improved cognitive function [65]
494 elderly persons with cognitive impairment 300 mg/day PS supplements Improved cognitive function in 6 months [66]